Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cyfuse Biomedical is a Japan-based regenerative medicine and biofabrication company developing scaffold-free 3D cellular products and related bio 3D printer systems. Its core platform uses spheroids and proprietary Bio 3D printing methods to fabricate tissues and organs composed only of cells, with applications spanning regenerative medicine, drug discovery, and research use. The company markets bio 3D printers such as Regenova and S-PIKE and also develops therapeutic tissue products including nerve conduits, osteochondral grafts, and vascular grafts. Cyfuse collaborates closely with Japanese academic medical centers to advance clinical research in peripheral nerve, vascular, dental, and orthopedic regeneration. It is publicly listed in Japan and remains focused on translating its platform into commercial regenerative medicine products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cyfuse Biomedical.